Period
Achievement
Attachment
2017 / 06
Youshi Plant’s cytotoxicity freeze-dried and oral doses passed the inspection of TFDA.
2017 / 01
Youshi Plant’s oral products and Youshi Plant III’s active pharmaceutical ingredients obtained the GMP certification of PMDA of Japan.
2016 / 03
Youshi Plant III’s preparation products continued to meet the PIC/S GMP requirements.
2016 / 01
Youshi Plant’s animal drugs passed the inspection of Council of Agriculture and continued to meet the GMP requirements.
2015 / 12
Youshi Plant III’s preparation products continued to meet Japan’s GMP requirements.
2015 / 09
Yungshin’s biotech food plant obtained the FSSC22000:2005 and HACCP:2012 certification.
2015 / 09
Youshi Plant III’s preparation products continued to meet the PIC/S GMP requirements.
2015 / 08
Youshi Plant II’s active pharmaceutical ingredients meet the PIC/S GMP requirements.
2015 / 07
Youshi Plant’s anti-tumor injection products and Youshi Plant II’s active pharmaceutical ingredients obtained the GMP certification of Japan’s PMDA.
2015 / 07
The expansion of the general injection plant in Youshi Plant I passed the inspection of TFDA.
2014 / 12
Youshi Plant passed the inspection of TFDA and obtained the GMP certification in terms of medical devices.
2014 / 08
Youshi Plant II’s active pharmaceutical ingredients passed the inspection of PMDA of Japan.
2014 / 08
Youshi Plant’s general injection and anti-tumor injection products passed the inspection of PMDA of Japan.
2014 / 06
Youshi Plant II’s fermentation plant passed the GMP inspection of Australian animal drugs.
2014 / 05
Youshi Plant’s general injection passed the inspection PAI of US-FDA without deficiency.
2013 / 03
Youshi Plant and Youshi Plant III’s preparation products continued to meet the PIC/S GMP requirements.
2011 / 06
Trustworthy Quality-Yungshin Pharm Ind. Co. Ltd. was awarded 2011
Taiwan Excellent Enterprise Quality Award.
Taiwan Excellent Enterprise Quality Award.
2011 / 03
2011/03 Tapi mycin Lyo-Injection has been gained the license by department of health on March 24, 2011.
2011 / 01
The Taichung Youth Factory III in which reeze-dry dosage form has been approved by department of health inspection on January 13, 2011.
2011 / 01
With assistance of the production division and the QA department, we established a food testing laboratory accredited by the TFDA with compliance of the ISO / IEC 17025 international standard requirements.
2009 / 12
Lyophilized inject table dosage forms was developed and successfully commercialized in Youth Factory III, Taichung. The facility was approved by PMDA, Japan 28th December, 2009.
2009 / 07
The health supplement, HAC-Natolin Q10 Capsules was approved and successfully launched in Taiwan.
Meclofenamate filed to US DMF (No.22795).
Drug License of Cefepime dihydrochloride Injectable with strengths, 1 gm, 0.5gm, and 0.3 gm were approved in Jap
Meclofenamate filed to US DMF (No.22795).
Drug License of Cefepime dihydrochloride Injectable with strengths, 1 gm, 0.5gm, and 0.3 gm were approved in Jap
2008 / 11
API Licenses of Carvedilol and Meloxicam were approved by the Department of Health, Excutive Yuan, R.O.C (Taiwan).
2003 / 11
Passed 2003 State of the Biotechnology Quality Award nutrition and Health Food - JIA SHIH PEI Marie Claire Set .
2001
Passed 2001 Industrial Development Bureau "Second Industrial Sustaninable Excellence Award "
1995
Asia Money rated the Best & Appeal Small and Medium Enterprises by Top Biotechnology Industrial Technology Development Award
Won The Second Industrial Technology Development of Biological Science and Technology Development Award
Won The Second Industrial Technology Development of Biological Science and Technology Development Award
1994
National Biotechnology Industrial Development Award
Forbes rated the top 100 most potential small and medium business
Forbes rated the top 100 most potential small and medium business